JADA 2016-004 JADA vs J-4513

In October 2016 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4513 (the Athlete) after his sample tested positive for the prohibited substances drostanolone and clenbuterol.

After notification the Athlete gave a prompt admission about the intentional use of the substances, waived his right to be heard and filed a statement in his defence.

Considering the Athlete’s prompt admission and the seriousness of the violation JADA decides on 2 February 2017 to impose a 3 year and 9 month period of ineligibility on the Athlete starting on the date of the provisional suspension i.e. on 18 October 2016.

Original document

Parameters

Legal Source
National Decisions
Date
2 February 2017
Arbitrator
Suzuki, Hidenori
Original Source
Japan Anti-Doping Agency (JADA)
Country
Japan
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Prompt / Timely Admission
Waiver of "right to be heard"
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Japan Anti-Doping Agency (JADA)
Laboratories
Tokyo, Japan: Anti-Doping Laboratory
Doping classes
S1. Anabolic Agents
Substances
Clenbuterol
Drostanolone
Various
Retirement
Document type
Pdf file
Date generated
28 March 2017
Date of last modification
6 April 2017
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin